Dr Greyson Nakano, - Medicare Optometrist in Long Beach, CA

Dr Greyson Nakano, is a medicare enrolled "Optometrist" provider in Long Beach, California. His current practice location is 5901 E 7th St, Long Beach, California. You can reach out to his office (for appointments etc.) via phone at (562) 826-8000.

Dr Greyson Nakano is licensed to practice in California (license number 6974YJB) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1003212663.

Contact Information

Dr Greyson Nakano,
5901 E 7th St,
Long Beach, CA 90822-5201
(562) 826-8000
Not Available



Healthcare Provider's Profile

Full NameDr Greyson Nakano
GenderMale
SpecialityOptometrist
Location5901 E 7th St, Long Beach, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003212663
  • Provider Enumeration Date: 11/10/2014
  • Last Update Date: 11/10/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 5799093639
  • Enrollment ID: I20150926000439

Medical Identifiers

Medical identifiers for Dr Greyson Nakano such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003212663NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 6974YJB (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Greyson Nakano allows following entities to bill medicare on his behalf.
Provider NameKopolow & Girisgen Professional Corporation
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1518904622
PECOS PAC ID: 7618982596
Enrollment ID: O20060214000361

News Archive

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.

Hippo pathway identifies and prevents progression of abnormal cells into cancer

Researchers from Boston University School of Medicine report that a tumor suppressor pathway, called the Hippo pathway, is responsible for sensing abnormal chromosome numbers in cells and triggering cell cycle arrest, thus preventing progression into cancer.

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

Read more Medical News

› Verified 1 days ago

Provider NameGirisgen & Kopolow Od, Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1427382415
PECOS PAC ID: 6507993854
Enrollment ID: O20100419000796

News Archive

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.

Hippo pathway identifies and prevents progression of abnormal cells into cancer

Researchers from Boston University School of Medicine report that a tumor suppressor pathway, called the Hippo pathway, is responsible for sensing abnormal chromosome numbers in cells and triggering cell cycle arrest, thus preventing progression into cancer.

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Greyson Nakano is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Greyson Nakano,
5901 E 7th St,
Long Beach, CA 90822-5201

Ph: (562) 826-8000
Dr Greyson Nakano,
5901 E 7th St,
Long Beach, CA 90822-5201

Ph: (562) 826-8000

News Archive

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.

Hippo pathway identifies and prevents progression of abnormal cells into cancer

Researchers from Boston University School of Medicine report that a tumor suppressor pathway, called the Hippo pathway, is responsible for sensing abnormal chromosome numbers in cells and triggering cell cycle arrest, thus preventing progression into cancer.

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

Read more News

› Verified 1 days ago


Optometrist in Long Beach, CA

Beach Eyecare Optometry
Optometrist
Medicare: Medicare Enrolled
Practice Location: 5531 E Stearns St, Suite A, Long Beach, CA 90815
Phone: 562-596-3838    Fax: 562-596-3835
Luelinda Tomlin, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 4409 E Los Coyotes Diagonal, Long Beach, CA 90815
Phone: 562-437-1276    Fax: 562-494-3388
Dr. Frederick Alexei Huizar, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1412 E Wardlow Rd, Long Beach, CA 90807
Phone: 562-426-2614    
Ledia Samwil, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 5991 E Spring St, Long Beach, CA 90808
Phone: 562-938-9945    Fax: 562-496-0433
Uc2020 Optometry Pc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3000 E Anaheim St, Long Beach, CA 90804
Phone: 562-438-9438    Fax: 562-438-9430
Nuvision Optometry
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7509 Carson Blvd, Long Beach, CA 90808
Phone: 562-429-2991    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.